Serum levels of irisin and nesfatin-1 in multiple sclerosis
Autor: | Mustafa ALTAŞ, Ali Ulvi UCA, Turan AKDAĞ, Faruk Ömer ODABAŞ, Osman Serhat TOKGÖZ |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Arquivos de Neuro-Psiquiatria (2022) |
Druh dokumentu: | article |
ISSN: | 1678-4227 0004-282x |
DOI: | 10.1590/0004-282x-anp-2020-0520 |
Popis: | ABSTRACT Background: Multiple sclerosis (MS) is an inflammatory and neurodegenerative autoimmune chronic neurological disease. Currently, there are no effective serum biomarkers to verify MS diagnosis, to assess disease prognosis, and evaluate response to MS treatment. Objective: The present study is a preliminary assessment of irisin and nesfatin-1 serum levels in patients with relapsing- remitting MS (RRMS). Methods: A total of 86 participants, 42 patients with RRMS diagnosis and 44 healthy controls were included in the study. The serum irisin and nesfatin-1 parameters of the patients and control group members were analyzed. Results: Irisin and nesfatin-1 levels of the RRMS patients were significantly lower than the controls (z: -3.82, p |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |